Dupilumab for treating moderate to severe chronic obstructive pulmonary disease ID6235Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Itepekimab as add-on maintenance treatment for moderate to severe chronic obstructive pulmonary disease [ID6547]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC